Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.

Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Fluorescein Angiography
Gestational Age
Humans
Infant, Extremely Low Birth Weight
Infant, Newborn
Injections
Laser Coagulation
Male
Recurrence
Retinopathy of Prematurity
Vascular Endothelial Growth Factor A
Vitreous Body

authors with profiles

Michael P Blair